Acute Kidney Injury
Acute Kidney Injury is a condition classified under renal health. It concerns changes in renal function and may involve kidney tissues such as the renal tubules.
Acute Kidney Injury is classified under renal health, offering a focused starting point for understanding this condition.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
May not suit people with this condition
Supplements and practices linked to problems for people with this condition.
Infrared SaunapracticeUnclear
Sweating can reduce blood flow to the kidneys; with acute kidney injury, the resulting fluid depletion and increased metabolic demand may worsen low urine output and delay recovery.
Open the Infrared Sauna pageChagasupplementUnclear
Chaga mushroom-induced oxalate nephropathy has clinically manifested as nephrotic syndrome.
Open the Chaga page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this conditionNothing in this library is currently recorded as helping with Acute Kidney Injury. That means nothing is on file — not that nothing exists. Only 107 of 338 catalogued supplements have a written-up profile so far.
What to avoid
Interventions recorded as making it worse2 listedHighest probability
- →PracticesInfrared SaunaCertaintyLowSourceReference knowledge
Sweating can reduce blood flow to the kidneys; with acute kidney injury, the resulting fluid depletion and increased metabolic demand may worsen low urine output and delay recovery.
Open Infrared SaunaRationale
Sweating reduces renal perfusion; in acute kidney injury, this can worsen oliguria and delay recovery due to volume depletion and increased metabolic demand.
- →SupplementsChagaCertaintyLowSourceTheoretical
Chaga mushroom-induced oxalate nephropathy has clinically manifested as nephrotic syndrome.
Who was studied
- People with a condition
Study result
ingesting high doses of Chaga mushroom can cause acute oxalate nephropathy
Open ChagaRationale
ingesting high doses of Chaga mushroom can cause acute oxalate nephropathy
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Acute Kidney Injury is a condition classified under renal health. It concerns changes in renal function and may involve kidney tissues such as the renal tubules. Research discussed for this condition also examines inflammation, oxidative stress, renal hemodynamics, and tubular injury. The findings described here come from animal models or reviews of animal research, so they do not establish that the same effects occur in people. Clinical interpretation should involve a qualified clinician.
Evidence-backed options
The options associated with Acute Kidney Injury are supported mainly by preclinical findings rather than established clinical evidence in people. Berberine, Curcumin, and Vitamin K1 were evaluated in animal models, while Quercetin was described in a review of animal models. These findings suggest potential protective effects, but their relevance to people with Acute Kidney Injury remains uncertain.
Across the findings, the reported outcomes center on changes in renal function and markers of kidney injury. They do not establish that any option improves recovery, prevents complications, or changes outcomes in people. The evidence also does not show whether results differ by cause, severity, or health status.
Specific doses, treatment durations, and the time to any observed effect are not established here. Human evidence, including how quickly benefits might appear or whether findings are consistent in clinical care, is also not provided. These limitations make the options unsuitable for interpreting as established treatments. Acute Kidney Injury can require medical assessment, so any consideration of supplements in this setting should be discussed with a clinician.
What to avoid
During acute kidney injury, reduced kidney filtration can make substances that are normally cleared by the kidneys accumulate. Potassium is flagged because impaired potassium excretion can allow supplementation to raise potassium levels rapidly, potentially causing life-threatening hyperkalemia. Magnesium is similarly flagged because reduced renal clearance may allow supplemental or laxative-dose magnesium to accumulate, with possible hypotension, conduction abnormalities, weakness, and respiratory depression.
Creatine is flagged for a different reason. Nonessential creatine supplementation can complicate assessment during active acute kidney injury by confounding serial serum-creatinine measurements while renal function is unstable.
Chaga is flagged because Chaga mushroom-induced oxalate nephropathy has been reported to clinically manifest as nephrotic syndrome. This provides a kidney-specific concern that is distinct from the clearance-related concerns involving potassium and magnesium.
Because acute kidney injury can involve rapidly changing kidney function and electrolyte handling, the suitability of these products depends on the clinical context. Anyone with a medical condition should consult a clinician before using supplements, including products marketed for general wellness.